[Federal Register Volume 76, Number 110 (Wednesday, June 8, 2011)]
[Notices]
[Page 33305]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2011-14200]



[[Page 33305]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP): Initial Review

    The meeting announced below concerns Program to Support New 
Implementation of State or Territorial Public Health Laboratory 
Capacity for Newborn Bloodspot Screening of Severe Combined Immune 
Deficiency (SCID) (U01), Funding Opportunity Announcement (FOA) EH11-
001, initial review.
    In accordance with Section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the aforementioned meeting:

    Time and Date: 8 a.m.--5 p.m., July 11, 2011 (Closed).
    Place: Intercontinental Hotel Buckhead, 3315 Peachtree Road, 
NE., Atlanta, Georgia 30326, Telephone: (404) 946-9000.
    Status: The meeting will be closed to the public in accordance 
with provisions set forth in Section 552b(c) (4) and (6), Title 5 
U.S.C., and the Determination of the Director, Management Analysis 
and Services Office, CDC, pursuant to Public Law 92-463.
    Matters to be Discussed: The meeting will include the initial 
review, discussion, and evaluation of applications received in 
response to ``Program to Support New Implementation of State or 
Territorial Public Health Laboratory Capacity for Newborn Bloodspot 
Screening of SCID (U01), FOA EH11-001, initial review.''
    Contact Person for More Information: J. Felix Rogers, Ph.D., 
M.P.H., Scientific Review Officer, CDC, 4770 Buford Highway, 
Mailstop F63, Atlanta, Georgia 30341, Telephone: (770) 488-4334.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention, 
and the Agency for Toxic Substances and Disease Registry.

    Dated: May 27, 2011.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 2011-14200 Filed 6-7-11; 8:45 am]
BILLING CODE 4163-18-P